India · Delayed Price · Currency is INR Tatva Chintan Pharma Chem Statistics
Total Valuation
BOM:543321 has a market cap or net worth of INR 26.90 billion. The enterprise value is 27.56 billion.
| Market Cap | 26.90B |
| Enterprise Value | 27.56B |
Important Dates
The next estimated earnings date is Monday, May 4, 2026.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | Sep 12, 2025 |
Share Statistics
| Current Share Class | 23.39M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.19% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 74.16% |
| Owned by Institutions (%) | 9.32% |
| Float | 6.04M |
Valuation Ratios
The trailing PE ratio is 82.11 and the forward PE ratio is 43.85.
| PE Ratio | 82.11 |
| Forward PE | 43.85 |
| PS Ratio | 5.61 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 84.12 |
| EV / Sales | 5.75 |
| EV / EBITDA | 41.03 |
| EV / EBIT | 70.00 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | n/a |
| Interest Coverage | 27.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.71% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.06M |
| Profits Per Employee | 482,518 |
| Employee Count | 679 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:543321 has paid 96.85 million in taxes.
| Income Tax | 96.85M |
| Effective Tax Rate | 22.82% |
Stock Price Statistics
The stock price has increased by +62.49% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +62.49% |
| 50-Day Moving Average | 1,233.58 |
| 200-Day Moving Average | 1,172.34 |
| Relative Strength Index (RSI) | 46.13 |
| Average Volume (20 Days) | 2,796 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543321 had revenue of INR 4.80 billion and earned 327.63 million in profits. Earnings per share was 14.02.
| Revenue | 4.80B |
| Gross Profit | 2.47B |
| Operating Income | 393.72M |
| Pretax Income | 424.48M |
| Net Income | 327.63M |
| EBITDA | 669.26M |
| EBIT | 393.72M |
| Earnings Per Share (EPS) | 14.02 |
Balance Sheet
The company has 171.72 million in cash and 830.13 million in debt, with a net cash position of -658.41 million.
| Cash & Cash Equivalents | 171.72M |
| Total Debt | 830.13M |
| Net Cash | -658.41M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.54B |
| Book Value Per Share | 322.54 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 51.40%, with operating and profit margins of 8.21% and 6.83%.
| Gross Margin | 51.40% |
| Operating Margin | 8.21% |
| Pretax Margin | 8.85% |
| Profit Margin | 6.83% |
| EBITDA Margin | 13.96% |
| EBIT Margin | 8.21% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.19% |
| Shareholder Yield | 0.27% |
| Earnings Yield | 1.22% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |